Loss of UHRF2 Is Associated With Non-small Cell Lung Carcinoma Progression

Conclusion: Our findings indicate that UHRF2 is a tumor suppressor in NSCLC by influence TET2 expression and serve as a potential therapeutic target in NSCLC.

Source: Journal of Cancer - December 14, 2018 Category: Cancer & Oncology Authors: Chun Jin, Dian Xiong, Hao-Ran Li, Jia-Hao Jiang, Jian-Chao Qi, Jian-Yong Ding Tags: Research Paper Source Type: research